We observed that anti-VISTA 13F3 antibody induced potent tumor growth inhibition (TGI) when used in combination with anti-mPD-L1 (B16-F10 model) or anti-mPD-L1 and CTLA-4 (CT26 model) (Figure S7). The gene discussed is CTLA4; the disease is neoplasm.